A Pivotal Study of ZYN002 Cannabidiol (CBD) Transdermal Gel in Children and Adolescents With Fragile X Syndrome [CONNECT-FX (ZYN2-CL-016)]
Elizabeth Berry‐Kravis(Rush University Medical Center), Randi J. Hagerman(University of California Davis Medical Center), Dejan B. Budimirovic(Kennedy Krieger Institute), Craig A. Erickson(Cincinnati Children's Hospital Medical Center), Helen Heussler(NeuroDevelopment Center), Nicole Tartaglia(Children's Hospital Colorado), Jonathan Cohen(Digital Research Alliance of Canada), Thomas W Dobbins, Elizabeth Merikle(Covance (United States)), Terri Sebree(Zynerba Pharmaceuticals (United States)), Nancy Tich(Zynerba Pharmaceuticals (United States)), Joseph Palumbo(Zynerba Pharmaceuticals (United States))
Cited by 5
Abstract
Related Papers
No related papers found
Powered by citation graph analysis